Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback